Hematologic and surgical management of the dental patient with plasminogen activator deficiency.
Anticoagulation therapy is used to treat patients with a variety of hemostatic disorders in an attempt to prevent thrombus formation. A thorough understanding of the patient's medical history is essential before dental treatment that may require alteration of this anticoagulation therapy. Alteration of anticoagulation therapy should be undertaken only after consultation with the patient's physician because some patients are at greater risk than others for thrombus formation or hemorrhage. This case of a 29-year-old man with plasminogen activator deficiency illustrates how consultation can result in a coordinated treatment plan for medical and dental management formulated to help ensure safe surgical treatment for these medically compromised patients.
Scheitler
L E
LE
Dental Service, VA Medical Center, St. Louis, Mo.
Hart
N
N
Phillips
G
G
Weinberg
J B
JB
D000328:Adult; D001803:Blood Transfusion; D003730:Dental Care for Persons with Disabilities; D003793:Dental Restoration, Permanent; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D010510:Periodontal Diseases / Q000628:therapy; D010960:Plasminogen Activators / Q000172:deficiency*; D013927:Thrombosis / Q000517:prevention & control*; D014081:Tooth Extraction / Q000009:adverse effects; D014859:Warfarin / Q000627:therapeutic use
D014859:Warfarin; D006493:Heparin; D010960:Plasminogen Activators